The erythropoietin receptor is not required for the development, function, and aging of rods and cells in the retinal periphery

Molecular Vision

Volumn 20, Issue , 2014, Pages 307-324

  Caprara, Christian ^a   Britschgi, Corinne ^a   Samardzija, Marijana ^a   Grimm, Christian ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN RECEPTOR;

ADULT; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL AGING; CELL FUNCTION; CELL MATURATION; CELL POPULATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; ELECTRORETINOGRAPHY; EPOR GENE; FLUORESCENCE ANGIOGRAPHY; FROZEN SECTION; GENE; GENE DELETION; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HYPOXIA; INTRACELLULAR SIGNALING; LASER CAPTURE MICRODISSECTION; MOUSE; MUELLER CELL; NEWBORN; NONHUMAN; PHOTORECEPTOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RETINA AMACRINE CELL; RETINA BIPOLAR GANGLION CELL; RETINA BLOOD VESSEL; RETINA CELL; RETINA DEGENERATION; RETINA HORIZONTAL NERVE CELL; RETINA ROD;

ANIMALS; CELL AGING; CELL HYPOXIA; CELL SURVIVAL; ERYTHROPOIETIN; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; INTEGRASES; MICE; PROTEIN ISOFORMS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, ERYTHROPOIETIN; RETINAL NEOVASCULARIZATION; RETINAL ROD PHOTORECEPTOR CELLS; SIGNAL TRANSDUCTION;

EID: 84897833052     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Krantz SB. Erythropoietin. Blood 1991; 77:419-34. [PMID: 1991159]
2. Koury ST, Bondurant MC, Semenza GL, Koury MJ. The use of in situ hybridization to study erythropoietin gene expression in murine kidney and liver. Microsc Res Tech 1993; 25:29-39. [PMID: 8353306]
3. Koury MJ, Bondurant MC. Maintenance by erythropoietin of viability and maturation of murine erythroid precursor cells. J Cell Physiol 1988; 137:65-74. [PMID: 2459142]
4. Bondurant MC, Koury MJ. Anemia induces accumulation of erythropoietin mRNA in the kidney and liver. Mol Cell Biol 1986; 6:2731-3. [PMID: 3785209]
5. Jelkmann W. Molecular biology of erythropoietin. Intern Med 2004; 43:649-59. [PMID: 15468961]
6. Fried W, Kilbridge T, Krantz S, McDonald TP, Lange RD. Studies on extrarenal erythropoietin. J Lab Clin Med 1969; 73:244-8. [PMID: 5764021]
7. Fandrey J. Oxygen-dependent and tissue-specific regulation of erythropoietin gene expression. Am J Physiol Regul Integr Comp Physiol 2004; 286:R977-88. [PMID: 15142852]
8. Farrell F, Lee A. The erythropoietin receptor and its expression in tumor cells and other tissues. Oncologist 2004; 9:Suppl 518-30. [PMID: 15591419]
9. Juul SE, Yachnis AT, Christensen RD. Tissue distribution of erythropoietin and erythropoietin receptor in the developing human fetus. Early Hum Dev 1998; 52:235-49. [PMID: 9808074]
10. Xie Z, Wu X, Qiu Q, Gong Y, Song Y, Gu Q, Li C. Expression pattern of erythropoietin and erythropoietin receptor in experimental model of retinal detachment. Curr Eye Res 2007; 32:757-64. [PMID: 17882708]
11. Patel NS, Sharples EJ, Cuzzocrea S, Chatterjee PK, Britti D, Yaqoob MM, Thiemermann C. Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/ reperfusion in the mouse kidney in vivo. Kidney Int 2004; 66:983-9. [PMID: 15327391]
12. Parsa CJ, Matsumoto A, Kim J, Riel RU, Pascal LS, Walton GB, Thompson RB, Petrofski JA, Annex BH, Stamler JS, Koch WJ. A novel protective effect of erythropoietin in the infarcted heart. J Clin Invest 2003; 112:999-1007. [PMID: 14523037]
13. Cai Z, Manalo DJ, Wei G, Rodriguez ER, Fox-Talbot K, Lu H, Zweier JL, Semenza GL. Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Circulation 2003; 108:79-85. [PMID: 12796124]
14. Brines ML, Ghezzi P, Keenan S, Agnello D, de Lanerolle NC, Cerami C, Itri LM, Cerami A. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci USA 2000; 97:10526-31. [PMID: 10984541]
15. Fu QL, Wu W, Wang H, Li X, Lee VW, So KF. Up-regulated endogenous erythropoietin/erythropoietin receptor system and exogenous erythropoietin rescue retinal ganglion cells after chronic ocular hypertension. Cell Mol Neurobiol 2008; 28:317-29. [PMID: 17554621]
16. Weishaupt JH, Rohde G, Polking E, Siren AL, Ehrenreich H, Bahr M. Effect of erythropoietin axotomy-induced apoptosis in rat retinal ganglion cells. Invest Ophthalmol Vis Sci 2004; 45:1514-22. [PMID: 15111610]
17. Tsai JC, Wu L, Worgul B, Forbes M, Cao J. Intravitreal administration of erythropoietin and preservation of retinal ganglion cells in an experimental rat model of glaucoma. Curr Eye Res 2005; 30:1025-31. [PMID: 16282136]
18. Zhong L, Bradley J, Schubert W, Ahmed E, Adamis AP, Shima DT, Robinson GS, Ng YS. Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice. Invest Ophthalmol Vis Sci 2007; 48:1212-8. [PMID: 17325165]
19. Grimm C, Wenzel A, Groszer M, Mayser H, Seeliger M, Samardzija M, Bauer C, Gassmann M, Reme CE. HIF1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat Med 2002; 8:718-24. [PMID: 12068288]
20. Wu H, Liu X, Jaenisch R, Lodish HF. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 1995; 83:59-67. [PMID: 7553874]
21. Lin CS, Lim SK, D'Agati V, Costantini F. Differential effects of an erythropoietin receptor gene disruption on primitive and definitive erythropoiesis. Genes Dev 1996; 10:154-64. [PMID: 8566749]
22. Yu X, Shacka JJ, Eells JB, Suarez-Quian C, Przygodzki RM, Beleslin-Cokic B, Lin CS, Nikodem VM, Hempstead B, Flanders KC, Costantini F, Noguchi CT. Erythropoietin receptor signalling is required for normal brain development. Development 2002; 129:505-16. [PMID: 11807041]
23. Tsai PT, Ohab JJ, Kertesz N, Groszer M, Matter C, Gao J, Liu X, Wu H, Carmichael ST. A critical role of erythropoietin receptor in neurogenesis and post-stroke recovery. J Neurosci 2006; 26:1269-74. [PMID: 16436614]
24. Chan-Ling T, Gock B, Stone J. The effect of oxygen on vasoformative cell division. Evidence that 'physiological hypoxia' is the stimulus for normal retinal vasculogenesis. Invest Ophthalmol Vis Sci 1995; 36:1201-14. [PMID: 7775098]
25. Noguchi CT, Wang L, Rogers HM, Teng R, Jia Y. Survivaland proliferative roles of erythropoietin beyond the erythroid lineage. Expert Rev Mol Med 2008; 10:e36-[PMID: 19040789]
26. Kertesz N, Wu J, Chen TH, Sucov HM, Wu H. The role of erythropoietin in regulating angiogenesis. Dev Biol 2004; 276:101-10. [PMID: 15531367]
27. Chung H, Lee H, Lamoke F, Hrushesky WJ, Wood PA, Jahng WJ. Neuroprotective role of erythropoietin by antiapoptosis in the retina. J Neurosci Res 2009; 87:2365-74. [PMID: 19301424]
28. Ashery-Padan R, Marquardt T, Zhou X, Gruss P. Pax6 activity in the lens primordium is required for lens formation and for correct placement of a single retina in the eye. Genes Dev 2000; 14:2701-11. [PMID: 11069887]
29. Le YZ, Zheng L, Zheng W, Ash JD, Agbaga MP, Zhu M, Anderson RE. Mouse opsin promoter-directed Cre recombinase expression in transgenic mice. Mol Vis 2006; 12:389-98. [PMID: 16636658]
30. Madisen L, Zwingman TA, Sunkin SM, Oh SW, Zariwala HA, Gu H, Ng LL, Palmiter RD, Hawrylycz MJ, Jones AR, Lein ES, Zeng H. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat Neurosci 2010; 13:133-40. [PMID: 20023653]
31. Lange C, Heynen SR, Tanimoto N, Thiersch M, Le YZ, Meneau I, Seeliger MW, Samardzija M, Caprara C, Grimm C. Normoxic activation of hypoxia inducible factors in photoreceptors provides transient protection against light induced retinal degeneration. Invest Ophthalmol Vis Sci 2011; 52:5872-80. [PMID: 21447692]
32. Heynen SR, Meneau I, Caprara C, Samardzija M, Imsand C, Levine EM, Grimm C. CDC42 Is Required for Tissue Lamination and Cell Survival in the Mouse Retina. PLoS ONE 2013; 8:e53806-[PMID: 23372671
33. Tanimoto N, Muehlfriedel RL, Fischer MD, Fahl E, Humphries P, Biel M, Seeliger MW. Vision tests in the mouse: Functional phenotyping with electroretinography. Front Biosci 2009; 14:2730-7. [PMID: 19273231]
34. Nagao M, Masuda S, Abe S, Ueda M, Sasaki R. Production and ligand-binding characteristics of the soluble form of murine erythropoietin receptor. Biochem Biophys Res Commun 1992; 188:888-97. [PMID: 1445329]
35. Harris KW, Winkelmann JC. Enzyme-linked immunosorbent assay detects a potential soluble form of the erythropoietin receptor in human plasma. Am J Hematol 1996; 52:8-13. [PMID: 8638628]
36. Westphal G, Braun K, Debus J. Detection and quantification of the soluble form of the human erythropoietin receptor (sEpoR) in the growth medium of tumor cell lines and in the plasma of blood samples. Clin Exp Med 2002; 2:45-52. [PMID: 12049189]
37. Jubinsky PT, Krijanovski OI, Nathan DG, Tavernier J, Sieff CA. The beta chain of the interleukin-3 receptor functionally associates with the erythropoietin receptor. Blood 1997; 90:1867-73. [PMID: 9292519]
38. Blake TJ, Jenkins BJ, D'Andrea RJ, Gonda TJ. Functional cross-talk between cytokine receptors revealed by activating mutations in the extracellular domain of the beta-subunit of the GM-CSF receptor. J Leukoc Biol 2002; 72:1246-55. [PMID: 12488507]
39. Luche H, Weber O, Nageswara Rao T, Blum C, Fehling HJ. Faithful activation of an extra-bright red fluorescent protein in knock-in Cre-reporter mice ideally suited for lineage tracing studies. Eur J Immunol 2007; 37:43-53. [PMID: 17171761]
40. Caprara C, Thiersch M, Lange C, Joly S, Samardzija M, Grimm C. HIF1A is essential for the development of the intermediate plexus of the retinal vasculature. Invest Ophthalmol Vis Sci 2011; 52:2109-17. [PMID: 21212189]
41. Marquardt T, Ashery-Padan R, Andrejewski N, Scardigli R, Guillemot F, Gruss P. Pax6 is required for the multipotent state of retinal progenitor cells. Cell 2001; 105:43-55. [PMID: 11301001]
42. Elliott S, Busse L, Bass MB, Lu H, Sarosi I, Sinclair AM, Spahr C, Um M, Van G, Begley CG. Anti-Epo receptor antibodies do not predict Epo receptor expression. Blood 2006; 107:1892-5. [PMID: 16249375]
43. Kirkeby A, van Beek J, Nielsen J, Leist M, Helboe L. Functional and immunochemical characterisation of different antibodies against the erythropoietin receptor. J Neurosci Methods 2007; 164:50-8. [PMID: 17524492]
44. Digicaylioglu M, Bichet S, Marti HH, Wenger RH, Rivas LA, Bauer C, Gassmann M. Localization of specific erythropoietin binding sites in defined areas of the mouse brain. Proc Natl Acad Sci USA 1995; 92:3717-20. [PMID: 7731971]
45. Lewczuk P, Hasselblatt M, Kamrowski-Kruck H, Heyer A, Unzicker C, Siren AL, Ehrenreich H. Survival of hippocampal neurons in culture upon hypoxia: effect of erythropoietin. Neuroreport 2000; 11:3485-8. [PMID: 11095504]
46. Ruscher K, Freyer D, Karsch M, Isaev N, Megow D, Sawitzki B, Priller J, Dirnagl U, Meisel A. Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J Neurosci 2002; 22:10291-301. [PMID: 12451129]
47. Sun Y, Zhou C, Polk P, Nanda A, Zhang JH. Mechanisms of erythropoietin-induced brain protection in neonatal hypoxia-ischemia rat model. J Cereb Blood Flow Metab 2004; 24:259-70. [PMID: 14747752]
48. Chateauvieux S, Grigorakaki C, Morceau F, Dicato M, Diederich M. Erythropoietin, erythropoiesis and beyond. Biochem Pharmacol 2011; 82:1291-303. [PMID: 21782802]
49. Wen TC, Sadamoto Y, Tanaka J, Zhu PX, Nakata K, Ma YJ, Hata R, Sakanaka M. Erythropoietin protects neurons against chemical hypoxia and cerebral ischemic injury by up-regulating Bcl-xL expression. J Neurosci Res 2002; 67:795-803. [PMID: 11891794]
50. Renzi MJ, Farrell FX, Bittner A, Galindo JE, Morton M, Trinh H, Jolliffe LK. Erythropoietin induces changes in gene expression in PC-12 cells. Brain Res Mol Brain Res 2002; 104:86-95. [PMID: 12117554]
51. Chong ZZ, Kang JQ, Maiese K. Apaf-1, Bcl-xL, cytochrome c, and caspase-9 form the critical elements for cerebral vascular protection by erythropoietin. J Cereb Blood Flow Metab 2003; 23:320-30. [PMID: 12621307]
52. Shang YC, Chong ZZ, Wang S, Maiese K. Erythropoietin and Wnt1 govern pathways of mTOR, Apaf-1, and XIAP in inflammatory microglia. Curr Neurovasc Res 2011; 8:270-85. [PMID: 22023617]
53. Hu LM, Luo Y, Zhang J, Lei X, Shen J, Wu Y, Qin M, Unver YB, Zhong Y, Xu GT, Li W. EPO reduces reactive gliosis and stimulates neurotrophin expression in Muller cells. Front Biosci 2011; 3:1541-55. Elite Ed[PMID: 21622158]
54. Bringmann A, Wiedemann P. Müller glial cells in retinal disease. Ophthalmologica 2012; 227:1-19. [PMID: 21921569]
55. Youssoufian HA, Zon LI, Orkin SH, D'andrea AD, Lodish HF. Structure and transcription of the mouse erythropoietin receptor gene. Mol Cell Biol 1990; 10:3675-82. [PMID: 2162479]
56. Hardee ME, Cao Y, Fu P, Jiang X, Zhao Y, Rabbani ZN, Vujaskovic Z, Dewhirst MW, Arcasoy MO. Erythropoietin blockade inhibits the induction of tumor angiogenesis and progression. PLoS ONE 2007; 2:e549-[PMID: 17579721]
57. Colella P, Iodice C, Di Vicino U, Annunziata I, Surace EM, Auricchio A. Non-erythropoietic erythropoietin derivatives protect from light-induced and genetic photoreceptor degeneration. Hum Mol Genet 2011; 20:2251-62. [PMID: 21421996]
58. Chen ZY, Asavaritikrai P, Prchal JT, Noguchi CT. Endogenous erythropoietin signaling is required for normal neural progenitor cell proliferation. J Biol Chem 2007; 282:25875-83. [PMID: 17604282]
59. ed. Cell-intrinsic regulators of proliferation in vertebrate retinal progenitors. Seminars in cell & developmental biology 15(1); 2004; Elsevier; 2004.
60. Soliz J, Gassmann M, Joseph V. Soluble erythropoietin receptor is present in the mouse brain and is required for the ventilatory acclimatization to hypoxia. J Physiol 2007; 583:329-36. [PMID: 17584830]
61. Khankin EV, Mutter WP, Tamez H, Yuan H-T, Karumanchi SA, Thadhani R. Soluble erythropoietin receptor contributes to erythropoietin resistance in end-stage renal disease. PLoS ONE 2010; 5:e9246-[PMID: 20169072]
62. Maynard SE, Min J-Y, Merchan J, Lim K-H, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111:649-58. [PMID: 12618519]
63. Venkatesha S, Toporsian M, Lam C, Hanai J. Mammoto T, Kim YM, Bdolah Y, Lim K-H, Yuan H-T, Libermann TA. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006; 12:642-9. [PMID: 16751767]
64. Chen F, Xie Z, Wu X, Du W, Wang J, Zhu J, Ji H, Wang Y. Intravitreal Injection of Soluble Erythropoietin Receptor Exacerbates Photoreceptor Cell Apoptosis in a Rat Model of Retinal Detachment. Curr Eye Res 2012; 37:1156-64. [PMID: 22906152]
65. Brugniaux JV, Pialoux V, Foster GE, Duggan CTC, Eliasziw M, Hanly PJ, Poulin MJ. Effects of intermittent hypoxia on erythropoietin, soluble erythropoietin receptor and ventilation in humans. Eur Respir J 2011; 37:880-7. [PMID: 20947680]
66. Ribatti D, Presta M, Vacca A, Ria R, Giuliani R, Dell'Era P, Nico B, Roncali L, Dammacco F. Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Blood 1999; 93:2627-36. [PMID: 10194442]
67. Anagnostou A, Lee ES, Kessimian N, Levinson R, Steiner M. Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc Natl Acad Sci USA 1990; 87:5978-82. [PMID: 2165612]
68. Nakamura-Ishizu A, Kurihara T, Okuno Y, Ozawa Y, Kishi K, Goda N, Tsubota K, Okano H, Suda T, Kubota Y. The formation of an angiogenic astrocyte template is regulated by the neuroretina in a HIF-1-dependent manner. Dev Biol 2012; 363:106-14. [PMID: 22226979]
69. Barron C, Migliaccio AR, Migliaccio G, Jiang Y, Adamson JW, Ottolenghi S. Alternatively spliced mRNAs encoding soluble isoforms of the erythropoietin receptor in murine cell lines and bone marrow. Gene 1994; 147:263-8. [PMID: 7926812]